SCHEMBL7898002

SCHEMBL7898002

O=C(Cc1ccccc1)NC1CCN(c2ccc(OCc3ccccc3)cc2)CC1

nearest known ligand 0.76

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ME3 Q16798 1/20 0.76
SIGMAR1 Q99720 4/20 0.56
MAPT P10636 2/20 0.55
ALDH1A1 P00352 1/20 0.55
LMNA P02545 1/20 0.55
HTT P42858 1/20 0.55
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
RAB9A P51151 2/20 0.53
POLB P06746 1/20 0.53
NPC1 O15118 1/20 0.53
MCL1 Q07820 1/20 0.53
KDM1A O60341 1/20 0.53
MAOA P21397 1/20 0.53
MAOB P27338 1/20 0.53
CHRM4 P08173 2/20 0.53
EPHX2 P34913 1/20 0.52
CCR8 P51685 1/20 0.52
TP53 P04637 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7899165 0.88 ME3 (0.58) ME3MAPTALDH1A1LMNAHTT
SCHEMBL7899170 0.85 LTA4H (0.56) ME3MAPTALDH1A1LMNAHTT
SCHEMBL12321963 0.83 CKS1B (0.53) ME3MAPTALDH1A1LMNAHTT
SCHEMBL20887692 0.81 ACACB (0.61) ME3MAPTALDH1A1LMNAHTT
SCHEMBL20887689 0.81 ACACB (0.61) ME3MAPTALDH1A1LMNAHTT
SCHEMBL17888549 0.79 RAB9A (0.68) MAPTALDH1A1LMNAHTTRAB9A
SCHEMBL7902701 0.78 FOXM1 (0.53) ME3MAPTALDH1A1LMNAHTT
SCHEMBL1749465 0.78 RAB9A (0.55) ME3MAPTALDH1A1LMNAHTT
SCHEMBL32665123 0.77 ACACB (0.52) ME3KMT2A
SCHEMBL25169916 0.77 LTA4H (0.54) MAPTALDH1A1LMNAHTTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1141936-C Usage of aryl-cyclohexylamine derivant in anti-disturbance of central nervous system - 2004-03-17 CN disclosed
US-6184236-B1 Method of treating a neurodegenerative disease by administering an aryl-cyclohexylamine derivative HOFFMANN-LA ROCHE INC. 2001-02-06 US disclosed
CN-1248439-A Usage of aryl-cyclohexylamine derivant in anti-disturbance of central nervous system HOFFMAN LA ROCHE & CO AKTEINGE (DE) 2000-03-29 CN disclosed
EP-0982026-A2 Use of aryl-cyclohexylamine derivatives in the manufacture of NMDA receptor blockers F. HOFFMANN-LA ROCHE AG (CH) 2000-03-01 EP disclosed